*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Biotechnology Policy Panel Discussion:
"Ethics & Policy in Nanotech Development"
The field of Nanotechnology is growing quickly, particularly in the area of medical applications, such as cancer tracking. What effects do ethics and policy have on this dynamic environment? Our distinguished panel will answer your questions on nanotechnology development from guidelines for researching and implementing nanotechnology to educating the public on nanotechnology development.
Moderator:
Robert Butera, PhD, Chair of the Graduate program in Bioengineering at Georgia Tech, is also the Chair of the IEEE-EMBS Distinguished Lecturers Committee and a member of the IEEE_EMBS Neuroengineering Technical Advisory Committee.
Panelists:
Bryan Bockhop, Registered Patent Attorney at Bockhop & Associates, LLC, "concentrates his practice on patent prosecution and litigation primarily in the areas of electronics, optics and nanotechnology and complex mechanical systems."
Diane Lewis, PhD, President and founder of Georgia nanoFAB, is also the former Director of the Advanced Technology Development Center in Savannah and previously worked for EM Industries and Dow Chemical Company.
Jeff Stewart, Managing Director, HINRI Ventures LLC, has 25 years experience structuring financings and alliances for life science companies as a Partner and Executive Committee member of Arnall Golden Gregory LLP. Mr. Stewart is also the founding President and Chairman of the Georgia Nanotechnology Alliance.
FOOD WILL BE SERVED!
Sponsored by the School of Public Policy, GT Policy Research, and the Parker H. Petit Institute for Bioengineering and Biosciences.
